We report 3/5352 (0.056%) cases of endophthalmitis, which is within norms, but slightly higher than the latest literature on this subject, as the pooled endophthalmitis rate from 20 large retrospective studies on IVT anti-VEGF injections was reported to be 144/510,396 (0.028%) [37]. The gene discussed is VEGFA; the disease is endophthalmitis.